News

Earnings Estimate Revisions for 2seventy bio, Inc. For the fiscal year ending December 2024, this company is expected to earn -$0.50 per share, which is a change of 88.7% from the year-ago ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all of the ...
2seventy bio (NASDAQ:TSVT – Get Free Report)‘s stock had its “sell (e+)” rating reaffirmed by stock analysts at Weiss Ratings in a note issued to investors on Saturday,Weiss Ratings reports.
Shares of 2seventy bio took flight Tuesday after the biotechnology company agreed to be acquired by partner Bristol Myers Squibb. Bristol Myers is paying $5 a share in cash for 2seventy ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent highlights for the fourth quarter and full year ended December 31, 2024.
To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. 2seventy bio, the cell therapy spinout of Bluebird bio, is selling itself to Bristol Myers Squibb after ...
2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer. The company was founded ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Write to [email protected] 2seventy bio NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent highlights for the fourth quarter and full year ended December 31, 2024. “2024 was a pivotal year for 2seventy as ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...